ESC 365 - Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis

ESC Professional Premium Access

Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis

Session: Poster Session 2

Topic: Treatment

Speaker: Doctor B. David (Global City, PH)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Doctor Billy Joseph David

St Lukes Medical Center Global City, Global City (Philippines)

2 presentations

1 follower

32 more presentations in this session

The single-syringe versus the double-syringe techniques of adenosine administration for supraventricular tachycardia: a systematic review and meta-analysis

Speaker: Miss I. Miyawaki (Curitiba, BR)

Unexplained heart failure post pulmonary embolism: an observational study

Estimation of brain natriuretic peptide values from N-terminal pro brain natriuretic peptide levels and other factors

Speaker: Doctor Y. Kajikawa (Fukuyama, JP)

Clinical characteristics, management, and outcomes of acute heart failure patients in Central Asia.

Speaker: Doctor T. Abdurashidova (Lausanne, CH)

Heart failure (MYHF) registry: shedding light on lipid profiles and in-hospital outcome of heart failure patients

Speaker: Professor W. Wan Ahmad (Kuala Lumpur, MY)

Access the full session

Poster Session 2

Speakers: Doctor B. David, Miss I. Miyawaki, Doctor Y. Kajikawa, Doctor T. Abdurashidova, Professor W. Wan Ahmad

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources